Two Sigma Investments’s Day One Biopharmaceuticals DAWN Stock Holding History

Two Sigma Investments’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$890K	Buy	+41,500	New	+$585K	﹤0.01%	3349
2025 Q2	–	Sell	-69,895	Closed	-$554K	–	3239
2025 Q1	$554K	Sell	69,895 -201,881	-74%	-$2.17M	﹤0.01%	2481
2024 Q4	$3.44M	Sell	271,776 -135,725	-33%	-$1.89M	0.01%	1344
2024 Q3	$5.68M	Buy	407,501 +108,295	+36%	+$1.55M	0.01%	1023
2024 Q2	$4.12M	Buy	299,206 +278,794	+1,366%	+$4.08M	0.01%	1094
2024 Q1	$337K	Buy	+20,412	New	+$305K	﹤0.01%	2507
2023 Q2	–	Sell	-153,569	Closed	-$2.05M	–	3062
2023 Q1	$2.05M	Buy	+153,569	New	+$3M	0.01%	1362
2022 Q2	–	Sell	-60,190	Closed	-$597K	–	2601
2022 Q1	$597K	Buy	+60,190	New	+$795K	﹤0.01%	1935

Other funds holding DAWN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Two Sigma Investments's DAWN Position: Q1 2026 in Review

Two Sigma Investments opened a new position in Day One Biopharmaceuticals (DAWN) in Q1 2026: 41,500 shares worth $890K. The stake represents ﹤0.01% of the portfolio and ranks #3349 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in DAWN as recently as Q1 2025.

Two Sigma Investments first reported a position in DAWN in Q1 2022 and has held it in 8 quarters since. The position peaked at $5.68M in Q3 2024. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

Two Sigma Investments held 41,500 shares of Day One Biopharmaceuticals worth $890K as of Q1 2026.
Day One Biopharmaceuticals was a new Two Sigma Investments position in Q1 2026.
Day One Biopharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3349 holding.
Two Sigma Investments first reported a position in Day One Biopharmaceuticals in Q1 2022 and has held it in 8 quarters since.
Two Sigma Investments's Day One Biopharmaceuticals position peaked at $5.68M in Q3 2024.
206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.